期刊文献+

多剂量促性腺激素释放激素拮抗剂在体外受精—胚胎移植促超排卵中的应用效果 被引量:6

The Use of Multiple Dosages of Gonadotropin Releasing Hormone Antagonist for COH in IVF-ET
下载PDF
导出
摘要 目的探讨促性腺激素释放激素拮抗剂(GnRH-Ant)改良多剂量应用方案在体外受精-胚胎移植(IVF-ET)促超排卵中的使用效果。方法回顾性比较分析本中心2006年1~4月接受IVF-ET助孕治疗的患者中采用GnRH-Ant改良多剂量方案应用于26例年龄偏大的患者和采用促性腺激素释放激素激动剂(GnRH-a)长方案降调节方案应用于患者41例,观察其临床效果。结果两组促性腺激素的使用天数、受精率、优胚数、HCG日内膜厚度和E2值、流产率、妊娠率分别为(8.58±1.84)d和(7.71±2.06)d、88.17±17.96%和88.91±14.55%、(3.23±1.48)个和(3.78±2.31)个、(9.81±1.79)mm和(10.37±1.55)mm、(7060.27±4602.02)pmol/L和(7481.85±3852.84)pmol/L、11.54%和14.63%、50%和39.02%,两组之间比较无显著性差异;两组患者年龄、不孕年限、促性腺激素使用量、HCG日LH值、获卵数、MII卵子数分别为(34.73±15.46)和(28.76±3.08)岁、(6.54±4.11)和(4.2±2.08)年、(34.73±15.46)支和(19.32±10.45)支、(3.14±3.26)IU/L和(1.21±1.21)IU/L、(6.77±3.09)个和(9.66±3.58)个、6.23±2.79和8.88±3.60个,两组之间比较有显著性差异。结论GnRH-Ant联合促性腺激素促超排卵方案较GnRH-a长方案同样有效,尤其对于年龄较大患者比较适用,并可减轻患者的费用。 [Objective]To evaluate the efficacy of using multiple dosage of GnRH-Antagonist for COH in IVF-ET. [Methods]The clinical consequence of 77 infertile patients treated by IVF-ET was retrospectively analyzed from January to April 2006,26 of 77 cases accepted the regimen of GnRH-Antagonist and the rest accepted the long GnRH-a regimen. [Results]There was no significant difference between the two groups on the duration of treatment with gonadotropin,the rate of fertilization, the number of the good quality embryos, the endometrium thickness and the serum E2 level on the day of HCG administration and the rate of abortion and pregnancy. Otherwise there was significant difference between the two groups on the age of the patients ,the duration of the infertility ,the quantity of gonadotropin used ,the serum LH level on the day of HCG administration, the number of retrieved oocytes and the number of MII oocytes. [Conclusion]The multiple dosages of GnRH-Antagonist regimen have the same efficacy as the GnRH-a long regimen, and even more suitable for the elder patients. The treatment cost can be greatly reduced.
出处 《医学临床研究》 CAS 2007年第4期535-537,共3页 Journal of Clinical Research
关键词 超排卵 胚泡移植 受精 体外 促性腺素释放激素 superovulation embyo transfer gonadorelin
  • 相关文献

参考文献5

  • 1周士平,王树玉,黄醒华.辅助生育技术中常用的促超排卵药物[J].中国优生与遗传杂志,2003,11(1):78-80. 被引量:10
  • 2周灿权,钟依平.促性腺激素释放激素激动剂的临床应用[J].中国实用妇科与产科杂志,1999,15(12):754-756. 被引量:10
  • 3Dubourdieu S,Charbonnel B,DAcremont MF,et al.Effect of a gonadotropin-releasing hormone(GnRH)antagonist(Nal-Glu)during the periovulatory period:the luteinizing homone surge requires secretion of GnRH[J].J Clin Endocrinol Metab,1994,78:343-347.
  • 4Olivennes F,Fanchin R,Bouchard P,et al.The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization -embryo transfer program[J].Fertil Steril,1994,62:468-476.
  • 5Nakagawa K,Yamano S,Kamada M,et al.Quality of embryo does not affect the implantation rate of IVF-ET in infertile women with antisperm antibody[J].Fertil Steril,1999,72(6):1055 -1060.

二级参考文献18

  • 1庄广伦,翁世湘,周灿权.小剂量生长激素在体外受精超排卵周期中的作用[J].中华妇产科杂志,1994,29(8):471-474. 被引量:36
  • 2张镜如.生理学(第4版)[M].北京:人民卫生出版社,1996.401-403.
  • 3裘法祖.外科学(第4版)[M].北京:人民卫生出版社,1997.551.
  • 4[1]Biljan MM, Mahutte NG, Tulandi T, et al. Prospective randomized double-blind trail of the correlation between time of administration and antiestrogenic effects of clomiphene citrate on reproductive end ovgans. Fertil Steril, 1999, 71(4):633-638
  • 5[3]De Leo V, la Marca A, Ditto A, et al. Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrone. Fertil Steril, 1999, 72(2) :282-285
  • 6[4]Branigan EF, Estes MA. Treatment of chronic anovulation resistant to clomiphene citrate (CC) by using oral contraceptive ovarian suppression followed by reprent CC treatment. Fertil Steril, 1999, 71(3) :544-546
  • 7[5]Matikainen T, DE Leew R, Mannaerts B, et al. Circulating bioactive and immunoreactive recombinant human follicle simulating hormone after administration to gonadotropin deficient subjects. Fertil Steril, 1994, 61:62-69
  • 8[6]De Leew R, Mulders J, Voortman G, et al. Structure function relationship of recombinant follicle stimulating hormone. Hum Reprod,1996, 2: 361-369
  • 9[7]Hoomans EHM, Andersen AN, et al. A prospective, randomized clinical trail comparing 150IU recombinant follicles stimulating hormone( Metrodin-HP)in a fixed dose regimen in women undergoing ovarian stimulation. Hum Reprod, 1999, 14:2442-2447
  • 10[8]Out HJ, Mannaerts BMJL, Driessen SGAT, et al. A prospective,randomized assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone in in-vitro fertilization. Hum Reprod, 1995, 10: 2534-2540

共引文献18

同被引文献44

  • 1李洁,梁晓燕.GnRH-a/GnRH-A在诱导排卵治疗中的临床应用[J].实用妇产科杂志,2007,23(3):138-139. 被引量:7
  • 2陈士岭,尹敏娜,孙玲,李红,陈薪,宋华东,何锦霞,朱亮,郉福祺.在体外受精周期中应用促性腺激素释放激素拮抗剂方案的临床分析[J].南方医科大学学报,2007,27(5):588-590. 被引量:6
  • 3Ragni G, Vegetti W, Riccaboni A, et al. Comparis on of GnRH agonists and ant aganists in assist ed reproducti on cycles of pa- tients at high risk of ovarian hyperstimulations yndrome [ J ]. Hum Reprod, 2005,20 (9) :2421-2425.
  • 4Bart CJ, Fauser MD, Paul D. Why is the clinical acceptance of gonadotropin-releasing hormone antagonist co-treatment duringovar- ian hyperstimulation for in vitro fertilization so slow [ J ]. Fertil Steril, 2005,83 (6) : 1607-1611.
  • 5Bodri D, Sunkara SK, Coomarasamy A. Gonadotropinreleasing hormone agonists versus antagonists for controlled ovarian hypers- timulation in oocyte donors: asystematic reviewand recta-analysis [J]. Fertil Steril, 2011,95(1 ):164-169.
  • 6Check ME, Check JH, Choel JK, et al. Effect of antagonists vs ag- onists on in vitro fertilization outcome [ J ]. Clin Exp Obstet Gyne- col, 2004,31 (4) :257-259.
  • 7Tarlatzis BC, Fauser BC, Kolibianakis EM, et al. GnRH antago- nists in ovarian stimulation for IVF [ J ]. Hum Reprod Update, 2006,12(4) :333-340.
  • 8Shapiro DB. GnRH ant agonists normal responder patients [ J ]. Fertil Steril, 2003,80( Suppl 1 ) :8-15.
  • 9Griesinger G, Felberbaum R, Dicdrich K. GnPttt antagoni stsino- varian stimulation: atreatment regimen of clinicians second choice Data from the Germ annational IVF registry [ J ]. Hum Reprod, 2005,20(9) :2373-2375.
  • 10Fauser BC, Devroey P. Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow ? [ J ] Fertil Steril, 2005,83 : 1607-1611

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部